Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
NCT03115619
·
clinicaltrials.gov ↗
COMPLETED
Status
102
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG:
Pirfenidone
Sponsor
Hoffmann-La Roche